Showing results (331-340 of 343) with videos related to
Sort By:
Pageof 35
Nature Communications|January 13, 2026
Osimertinib with or without savolitinib as first-line treatment for MET-aberrant, EGFR-mutant NSCLC: randomized phase 2 trial (FLOWERS)Anna Li, Wei-Neng Feng, Juan Li, et al.Hepatology (Baltimore, Md.)|November 4, 2016
Yes-associated protein/TEA domain family member and hepatocyte nuclear factor 4-alpha (HNF4α) repress reciprocally to regulate hepatocarcinogenesis in rats and miceWang-Yu Cai, Ling-Yun Lin, Han Hao, et al.Military Medical Research|November 8, 2023
Caveolin-1 is critical for hepatic iron storage capacity in the development of nonalcoholic fatty liver diseaseGuang-Hui Deng, Chao-Feng Wu, Yun-Jia Li, et al.Gastroenterology|December 2, 2015
OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal TumorsGuo-Dong Ye, Guang-Bin Sun, Peng Jiao, et al.Journal of Virology|January 23, 2023
A SARS-CoV-2-Related Virus from Malayan Pangolin Causes Lung Infection without Severe Disease in Human ACE2-Transgenic MiceMei-Qin Liu, Hao-Feng Lin, Jing Li, et al.Experimental Neurology|November 23, 2021
Blockade of adenosine A2A receptor alleviates cognitive dysfunction after chronic exposure to intermittent hypoxia in miceXiu-Cui Li, Fang-Fang Hong, Yun-Jia Tu, et al.Clinical Rheumatology|October 4, 2018
The efficacy and safety of total glucosides of peony in the treatment of primary Sjögren's syndrome: a multi-center, randomized, double-blinded, placebo-controlled clinical trialXia Liu, Xiaomei Li, Xiangpei Li, et al.Clinical Rheumatology|December 5, 2018
Correction to: the efficacy and safety of total glucosides of peony in the treatment of primary Sjögren's syndrome: a multi-center, randomized, double-blinded, placebo-controlled clinical trialXia Liu, Xiaomei Li, Xiangpei Li, et al.Journal of Cell Science|October 9, 2013
A double-negative feedback loop between Wnt-β-catenin signaling and HNF4α regulates epithelial-mesenchymal transition in hepatocellular carcinomaMeng Yang, Sheng-Nan Li, Khalid M Anjum, et al.Frontiers in Immunology|November 17, 2022
Research progress of bile biomarkers and their immunoregulatory role in biliary tract cancersYun-Cheng Li, Kang-Shuai Li, Zeng-Li Liu, et al.Pageof 35